EGFR and breast adenocarcinoma: The human mammary adenocarcinoma cell line MDA-MB-468 was selected as suitable model for method evaluation, since it harbors an EGFR amplification and shows strong EGFR overexpression as well as displays a stemness/committed progenitor cell phenotype [6], [7].